Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21763219> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q21763219 subject Q7071513.
- Q21763219 subject Q7204516.
- Q21763219 subject Q7334131.
- Q21763219 subject Q7579524.
- Q21763219 subject Q8878163.
- Q21763219 abstract "Alectinib (marketed as Alecensa) is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small cell lung cancer (NSCLC). It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.".
- Q21763219 thumbnail Alectinib_skeletal.svg?width=300.
- Q21763219 wikiPageExternalLink record_view_open.asp?newDrugID=6100.
- Q21763219 wikiPageWikiLink Q17824987.
- Q21763219 wikiPageWikiLink Q2112244.
- Q21763219 wikiPageWikiLink Q212646.
- Q21763219 wikiPageWikiLink Q3658562.
- Q21763219 wikiPageWikiLink Q5186964.
- Q21763219 wikiPageWikiLink Q5323525.
- Q21763219 wikiPageWikiLink Q7071513.
- Q21763219 wikiPageWikiLink Q7204516.
- Q21763219 wikiPageWikiLink Q7334131.
- Q21763219 wikiPageWikiLink Q750619.
- Q21763219 wikiPageWikiLink Q7579524.
- Q21763219 wikiPageWikiLink Q8878163.
- Q21763219 type ChemicalSubstance.
- Q21763219 type Drug.
- Q21763219 type ChemicalObject.
- Q21763219 type Thing.
- Q21763219 type Q8386.
- Q21763219 comment "Alectinib (marketed as Alecensa) is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small cell lung cancer (NSCLC). It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.".
- Q21763219 label "Alectinib".
- Q21763219 depiction Alectinib_skeletal.svg.